DC
MDCO

Deere & Company’s Medicines Co MDCO Stock Holding History

Deere & Company’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-9,358
Closed -$262K – 1149
2015
Q1 		$262K Buy
+9,358
New +$263K 0.01% 782
2014
Q4 		– Sell
-19,223
Closed -$429K – 1102
2014
Q3 		$429K Sell
19,223
-6,222
-24% -$158K 0.02% 684
2014
Q2 		$739K Buy
25,445
+6,222
+32% +$166K 0.04% 487
2014
Q1 		$546K Buy
19,223
+1,785
+10% +$59.1K 0.03% 607
2013
Q4 		$673K Hold
17,438
– – 0.03% 575
2013
Q3 		$585K Buy
+17,438
New +$555K 0.03% 574

Other funds holding MDCO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deere & Company's MDCO Position: Q2 2015 in Review

Deere & Company sold out of Medicines Co (MDCO) in Q2 2015, closing a stake of 9,358 shares — an estimated $262K sold.

Deere & Company first reported a position in MDCO in Q3 2013 and held it in 6 quarters. The position peaked at $739K in Q2 2014. 172 funds tracked by Wall St. Rank hold MDCO as of Q2 2015.

  • Deere & Company reported no remaining Medicines Co position as of Q2 2015 after selling out during the quarter.
  • Deere & Company sold 9,358 Medicines Co shares in Q2 2015, an estimated $262K.
  • Deere & Company first reported a position in Medicines Co in Q3 2013 and held it in 6 quarters.
  • Deere & Company's Medicines Co position peaked at $739K in Q2 2014.
  • 172 funds tracked by Wall St. Rank held Medicines Co as of Q2 2015.

Based on Deere & Company's 13F filing for Q2 2015, filed 13 Aug 2015.